BigHat Biosciences — AI platform for designing antibody therapeutics
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Get it by email
Companies like BigHat Biosciences go out every weekday morning. One-click unsubscribe.
- Round
- $75M Series C
- Sectors
- Biotechnology
- Logged
- September 26, 2026, in issue #39
- Website
- www.bighatbio.com
More in biotechnology
$1M · galy.co
GALY Co. — Cocoa and cotton grown from cells for brands
GALY grows cocoa and cotton from cells using biological processes, supplying brands with traceable, scalable ingredients without traditional farming.
Information technologyBiotechnology$1M+
$100M Series C · delixtherapeutics.com
Delix Therapeutics — Non-hallucinogenic psychedelic drugs for mental health
Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.
BiotechnologyData and analyticsHealthcareSV Health neurodegen fundStrategic Pharma$100M+ · +1 · +4
$4.7M Seed · getpeppermint.ai
Peppermint — Billing and collections for clinical trial sites
Peppermint is a software company based in San Francisco that focuses on AI-powered financial operations for clinical research teams. It aims to modernize the financial infrastructure used by hospital systems and research sites to manage clinical trials. Founded in 2026, the company provides a platform that automates billing, invoicing, and collections. This platform integrates with existing clinical trial management systems to streamline revenue cycle management.
BiotechnologySoftwareHealthcareEvan MooreBenjamin MannNight Capital · +8 · +11